Document is current
Any future updates will be listed below
-
Authors
Ostroff, Jamie S. https://orcid.org/0000-0003-2671-5680
Shelley, Donna R.
Chichester, Lou-Anne
King, Jennifer C.
Li, Yuelin
Schofield, Elizabeth
Ciupek, Andrew
Criswell, Angela
Acharya, Rashmi
Banerjee, Smita C.
Elkin, Elena B.
Lynch, Kathleen
Weiner, Bryan J.
Orlow, Irene
Martin, Chloé M.
Chan, Sharon V.
Frederico, Victoria
Camille, Phillip
Holland, Susan
Kenney, Jessica
-
Funding
Funding for this research was provided by:
National Cancer Institute (P30CA008748, R01CA207442)
- License Information
-
More Information
Article History
Received: 1 April 2022
Accepted: 19 July 2022
First Online: 17 August 2022
Declarations
:
: The study was approved by the Memorial Sloan Kettering Cancer Center Institutional Review Board serving as the single IRB for this multi-site clinical trial. Informed consent was obtained from all study participants prior to participation in study activities.
: A sample of our verbal consent scripts has been included in the supplemental materials.
: Jamie Ostroff has received royalties from UptoDate. Dr. Elkin receives research funding from Pfizer for an unrelated study. The other co-authors declare that they have no competing interests. All research was conducted in adherence to the ethical standard of the responsible committee on human experimentation (institutional and national) and with Helsinki Declaration.
